Published in
Springer, Neurology and Therapy, 2(11), p. 893-903, 2022
DOI: 10.1007/s40120-022-00327-x
Links
Tools
Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons Learned
Journal article published in 2022 by
Kyle M. Blackburn 
,
David A. Denney,
Steven C. Hopkins,
Steven A. Vernino
,
David A. Denney,
Steven C. Hopkins,
Steven A. Vernino
This paper is made freely available by the publisher.
Full text: Download
Data provided by 